Congress Trades
Latest disclosures
| Chamber | Transaction Date | Member | Owner ▲ | Asset | Action | Amount | Ticker | Δ Since Trade |
|---|---|---|---|---|---|---|---|---|
| House | Aug. 14, 2025 | Julie Johnson | Joint | Eli Lilly and Co | SALE | $1,001 - $15,000 | LLY | ▲ +26.07% |
| Senate | Oct. 3, 2023 | Markwayne Mullin | Joint | Eli Lilly and Company Common Stock | PURCHASE | $1,001 - $15,000 | LLY | ▲ +64.29% |
| Senate | Aug. 11, 2025 | John Boozman | Joint | Eli Lilly and Co | PURCHASE | $1,001 - $15,000 | LLY | ▲ +35.84% |
| House | Jan. 18, 2023 | Greg Landsman | Joint | Eli Lilly and Company Common Stock | PURCHASE | $1,001 - $15,000 | LLY | ▲ +145.12% |
| House | Apr. 7, 2025 | Julie Johnson | Joint | Eli Lilly and Co | SALE | $1,001 - $15,000 | LLY | ▲ +19.22% |
| Senate | Apr. 16, 2020 | David Perdue | Joint | Eli Lilly and Company | SALE (FULL) | $1,001 - $15,000 | LLY | ▲ +457.66% |
| House | Nov. 8, 2024 | Greg Landsman | Joint | Eli Lilly and Co | SALE | $15,001 - $50,000 | LLY | ▲ +3.77% |
| Senate | Jan. 3, 2024 | Tommy Tuberville | Joint | Eli Lilly and Company Common Stock | SALE (PARTIAL) | $15,001 - $50,000 | LLY | ▲ +39.69% |
| House | Oct. 16, 2024 | Josh Gottheimer | Joint | Eli Lilly and Co | SALE | $1,001 - $15,000 | LLY | ▼ -5.84% |
| House | Jun. 3, 2024 | Greg Landsman | Joint | Eli Lilly and Company Common Stock | SALE (PARTIAL) | $1,001 - $15,000 | LLY | ▲ +3.80% |
| House | Nov. 19, 2024 | Josh Gottheimer | Joint | Eli Lilly and Company Common Stock | SALE (PARTIAL) | $1,001 - $15,000 | LLY | ▲ +18.24% |
| Senate | Apr. 3, 2024 | Tommy Tuberville | Joint | Eli Lilly and Company Common Stock | SALE (FULL) | $15,001 - $50,000 | LLY | ▲ +11.19% |
| House | May. 13, 2025 | Josh Gottheimer | Joint | Eli Lilly and Co | SALE | $1,001 - $15,000 | LLY | ▲ +15.66% |
| House | May. 1, 2025 | Josh Gottheimer | Joint | Eli Lilly and Co | PURCHASE | $1,001 - $15,000 | LLY | ▲ +8.66% |
| House | Jul. 1, 2024 | Josh Gottheimer | Joint | Eli Lilly and Company Common Stock | SALE (PARTIAL) | $1,001 - $15,000 | LLY | ▼ -5.63% |
| Senate | Sep. 8, 2023 | Tommy Tuberville | Joint | Eli Lilly and Company Common Stock | SALE (PARTIAL) | $1,001 - $15,000 | LLY | ▲ +47.13% |
| House | Apr. 9, 2025 | Josh Gottheimer | Joint | Eli Lilly and Company Common Stock | SALE (PARTIAL) | $1,001 - $15,000 | LLY | ▲ +14.48% |
| House | Apr. 21, 2025 | Jonathan Jackson | Joint | Eli Lilly and Co | PURCHASE | $15,001 - $50,000 | LLY | ▲ +5.48% |
| Senate | Sep. 13, 2023 | Markwayne Mullin | Joint | Eli Lilly and Company | PURCHASE | $15,001 - $50,000 | LLY | ▲ +44.08% |
| House | Dec. 16, 2024 | Josh Gottheimer | Joint | Eli Lilly and Co | SALE | $1,001 - $15,000 | LLY | ▲ +10.77% |
| House | Mar. 10, 2025 | Josh Gottheimer | Joint | Eli Lilly and Co | SALE | $1,001 - $15,000 | LLY | ▲ +3.99% |
| House | Feb. 19, 2025 | Josh Gottheimer | Joint | Eli Lilly and Co | SALE | $1,001 - $15,000 | LLY | ▼ -0.48% |
| Senate | Jan. 14, 2022 | Tommy Tuberville | Joint | Eli Lilly and Company Common Stock | SALE (FULL) | $15,001 - $50,000 | LLY | ▲ +253.46% |
| House | Dec. 13, 2024 | Josh Gottheimer | Joint | Eli Lilly and Co | SALE | $1,001 - $15,000 | LLY | ▲ +9.34% |
| House | Dec. 11, 2024 | Josh Gottheimer | Joint | Eli Lilly and Co | SALE | $1,001 - $15,000 | LLY | ▲ +8.40% |
| House | Dec. 10, 2024 | Josh Gottheimer | Joint | Eli Lilly and Co | SALE | $1,001 - $15,000 | LLY | ▲ +7.91% |
| House | Dec. 9, 2024 | Josh Gottheimer | Joint | Eli Lilly and Co | SALE | $1,001 - $15,000 | LLY | ▲ +7.38% |
| House | Dec. 18, 2024 | Josh Gottheimer | Joint | Eli Lilly and Co | SALE | $1,001 - $15,000 | LLY | ▲ +12.83% |
| House | Dec. 12, 2024 | Josh Gottheimer | Joint | Eli Lilly and Co | SALE | $1,001 - $15,000 | LLY | ▲ +10.29% |
| Senate | Apr. 16, 2020 | David Perdue | Joint | Eli Lilly and Company | SALE (FULL) | $1,001 - $15,000 | LLY | ▲ +457.66% |
Last updated: Nov 2, 03:41